Redaptive, a Denver, CO-based Energy-as-a-Service provider, has raised $100 million in equity investment. Investors The investment came from the Canada Pension Plan Investment Board (CPP Investments), a global investment management organization based in Toronto. CPP Investments manages assets for over 22 million Canada Pension Plan contributors and beneficiaries worldwide, investing …
interface.ai, a New York-based provider of agentic AI solutions for community banks and credit unions, has raised $30 million in funding. Investors The round was led by Avataar Venture Partners, a growth-stage venture capital firm focused on scaling B2B and SaaS companies. Leveraging its unique #OperatingVC model, Avataar partners closely …
Oriole Networks, a London, UK-based AI optimization technology developer, has secured an additional $22 million in funding. Investors The round was led by Plural, with participation from existing investors, including UCL Technology Fund, XTX Ventures, Clean Growth Fund, and Dorilton Ventures. This latest funding brings Oriole's total capital raised this …
Cambri, a Helsinki, Finland-based AI-driven consumer insights and innovation platform, has secured €8 million in funding. Investors The round was led by new investors Octopus Ventures and S4S Ventures, alongside existing backers The 98, OpenOcean, and Spintop Ventures. Octopus Ventures, part of Octopus Group, is one of the most active …
MyFO, a Vancouver, BC-based platform for family offices and the wealth management professionals who serve them, has raised $3.5 million in funding. Investors The round was led by Rhino Ventures, a private investment firm based in the Netherlands, founded in 2012. Rhino Ventures focuses on value-based investments in growth companies …
Tookitaki, a Singapore-based anti-financial crime software provider, has secured strategic funding from True Global Ventures (TGV) Opportunity Fund. Investor True Global Ventures is a global venture capital firm focused on technology-driven businesses, particularly in AI, blockchain, and other disruptive industries. The TGV Opportunity Fund invests in late-stage technology companies with …
AIGEN Sciences, a Seoul, South Korea-based AI-driven new drug development company, has raised 12 billion KRW in funding. Investors Existing investors Partners Investment, Quad Asset Management, and Medytox Venture Investment, along with new investors Premier Partners, K2 Investment, and Scaleup Partners, participated in the round. AIGEN Sciences Use of Funds …
